Targeting the EGFR/PCNA Signaling Suppresses Tumor Growth of Triple-Negative Breast Cancer Cells with Cell-Penetrating PCNA Peptides

• Yung-Luen Yu ,

  * E-mail: ylyu@mail.cmu.edu.tw (YLY); mhung@mdanderson.org (MCH)

  Affiliations Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan, Department of Biotechnology, Asia University, Taichung, Taiwan

  ⨯
• Ruey-Hwang Chou,

  Affiliations Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan, Department of Biotechnology, Asia University, Taichung, Taiwan

  ⨯
• Jia-Hong Liang,

  Affiliation Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan

  ⨯
• Wei-Jung Chang,

  Affiliation Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan

  ⨯
• Kuo-Jung Su,

  Affiliations Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan, The Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University, Taichung, Taiwan

  ⨯
• Yen-Ju Tseng,

  Affiliation Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan

  ⨯
• Wei-Chien Huang,

  Affiliation Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan

  ⨯
• Shao-Chun Wang,

  Affiliation Department of Cancer and Cell Biology, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America

  ⨯
• Mien-Chie Hung

  * E-mail: ylyu@mail.cmu.edu.tw (YLY); mhung@mdanderson.org (MCH)

  Affiliations Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan, Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯